Ms. Barnett joined Chimerix in 2020 as Vice President Clinical Operations. She brings 25 years of clinical development experience with primary focus in Clinical Project Management and Clinical Operations. Prior to joining Chimerix, Ms. Barnett served as Vice President Clinical Operations for Advanced Accelerator Applications, a Novartis Company where she led the execution of the prostate cancer program and a highly complex Phase 3 program with radioligand therapy. She was previously with Endocyte, Inc prior to the acquisition by Novartis. Ms. Barnett also held numerous positions with Eli Lilly and Company where she simultaneously led multiple global Phase 3 oncology trials which led to product approvals. She has been responsible for global and regional clinical operations, including patient enrollment, protocol development, regulatory inspections, and project management with Novartis and Eli Lilly and Company. Ms. Barnett has a Bachelor of Science in Nursing from West Virginia University and a Master of Science in Nursing from Indiana University.
This post was written by tbe_admin